- Extubation Success in Premature Infants With Respiratory Distress Syndrome Treated With Bi-Level Nasal Continuous Positive Airway Pressure Versus Nasal Intermittent Positive Pressure Ventilation
- JBI Evidence-Based Practice Core Concept Courses
- Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the role of nurse practitioners (NPs) and physician assistants (PAs) in caring for patients with psoriasis.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify issues of nonadherence with psoriasis treatments and how NPs and PAs can assist patients in managing their psoriasis.
- Compare treatment options for psoriasis.
Disclosures
The authors and planners have disclosed that they have no financial relationships related to this article.
Technical assistance with editing and styling of the manuscript for submission was provided by Oxford PharmaGenesis, Inc., and was funded by Novartis Pharmaceuticals Corporation.The authors were fully responsible for all content and editorial decisions and received no financial support or other form of compensation related to the development of this manuscript. The opinions expressed in the manuscript are those of the authors, and Novartis Pharmaceuticals had no influence on the contents. LMA serves as speaker and/or consultant for AbbVie, Amgen, Celgene, Galderma, Janssen-Ortho Inc, LEO Pharma Inc, Lilly ICOS LLC, Merck, Novartis, and Pfizer. MSY serves as speaker and/or consultant for AbbVie, Celgene, Janssen, and Lilly, and as a clinical investigator for Amgen, Janssen, Novartis, Merck, Celgene, Pfizer, Galderma, and Lilly.
Price:
$20.00
Credits:
- ANCC 3.0 CH
- DC - BON 3.0 CH
- KY-BON 3.0 CH
- GA - BON 3.0 CH
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: JDNA0116A
Published: Jan/Feb 2016
Expires: 12/31/2026
Required Passing Score: 13/18 (72%)
Categories:
Advanced Practice Nursing
,
Dermatologic Conditions
Topics:
Biologic Therapies
,
Psoriasis